| Grant Title | Grantor | Amount | Award Date |
|---|
| Ghassan T. Wahbeh, MD | Genome-Wide Association (GWA) identified predictors of response to Anti-TNFα Therapy in Pediatric IBD | NIH NIDDK funding | | 2010 |
| Ghassan T. Wahbeh, MD | A Phase 2, open-label, multicenter study to assess the safety and efficacy of certolizumab pegol in children and adolescents with active Crohn’s disease (NURTURE Study) | UCB | | 2010 |
| Simon Horslen, MB ChB | Childhood Liver Disease Research and Education Network Clinical Center in SeattleRole | NIH/NIDDK | | July 1, 2009 |
| Simon Horslen, MB ChB | Pilot study of the safety and immunogenicity of a rotavirus vaccine in infants at risk for intestinal failure | Thrasher Research Fund | | May 14, 2009 |
| Karen Murray, MD | A Phase 3, Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection | Gilead Sciences, Inc. |
$56,849.00 | Jan. 1, 2009 |
| Karen Murray, MD | Limited Competition: Continuation of the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) | NIH |
$225,207.00 | Jan. 1, 2009 |
| Karen Murray | Childhood Liver Disease Research and Education Network Clinical Center in Seattle | NIH NIDDK |
$1,557,754.00 | Jan. 1, 2009 |
| David L. Suskind, MD | Curcumin in Pediatric Ulcerative colitis: A forced dose titration study | University of Washington Institute for Translational Health Science |
$24,000 | July 2008 - Aug. 2009 |
| Simon Horslen, MB ChB | Intestinal failure in children: A contemporary retrospective review by the Pediatric Intestinal Failure Consortium | NIH | | April 1, 2008 |
| Ghassan T. Wahbeh, MD | A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease | Centocor |
$15911 | 2008 |
| Karen Murray, MD | BARC CRN, Biliary atresia research consortium | NIH NIDDK |
$95,266.00 | Jan. 1, 2008 |
| Karen Murray, MD | Clinical Research Network in Hepatitis B Virus | NIH |
$311,878.00 | Jan. 1, 2008 |
| Simon Horslen, MB ChB | A Multi-Center Group to Study Acute Liver Failure in Children | NIH/NIDDK | | Sept. 15, 2005 |
| David L. Suskind, MD | Maternal microchimerism in Inflammatory Bowel Disease | Broad Foundation Medical Research Grant |
$142,000 | July 2005 - July 2007 |
| Simon Horslen, MB ChB | Studies in Pediatric Liver Transplantation | NIH | | May 6, 2005 |
| Karen Murray, MD | A phase 3 double-blind, randomized, placebo-controlled study of the safety and efficacy of Adefovir Dipivoxil in children and adolescents (age 2 to under 18) with chronic hepatitis B | Gilead Sciences, Inc. |
$128,327.00 | Jan. 1, 2004 |
| Karen Murray, MD | Pegylated interferon + - ribavirin for children with HCV | FDA-OPD-2002 Clinical Studies of Safety and Effectiveness of Orphan Products |
$99,650.00 | Jan. 1, 2003 |
| David L. Suskind, MD | Maternal microchimerism in Biliary Atresia | University of California San Francisco of Medicine Research, Evaluation and Allocation Committee (REAC) Grant |
$16,000 | June 2002 - June 2003 |
| Karen Murray, MD | CD4+ T-cell immunity in mother-child pairs infected with hepatitis C virus | Research Endorsement Fund |
$30,000.00 | Jan. 1, 2002 |
| Karen Murray, MD | Pediatric Acute liver failure study group | NIH/NIDDK |
$16,000.00 | 0101.05 |